May the indirect effects of cihhv-6 in transplant patients be exerted through the reactivation of the viral replicative machinery?

Transplantation

Volumn 92, Issue 9, 2011, Pages

  Potenza, Leonardo ^a   Barozzi, Patrizia ^a   Rossi, Giulio ^b   Riva, Giovanni ^a   Vallerini, Daniela ^a   Zanetti, Eleonora ^a   Quadrelli, Chiara ^a   Morselli, Monica ^a   Forghieri, Fabio ^a   MacCaferri, Monica ^a   Paolini, Ambra ^a   Marasca, Roberto ^a   Narni, Franco ^a   Luppi, Mario ^a  

^a UNIVERSITY HOSPITAL OF TRIESTE   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCYTE ANTIGEN; VALGANCICLOVIR; VIRUS DNA; VIRUS PROTEIN;

ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIVIRAL THERAPY; BONE MARROW BIOPSY; BONE MARROW CULTURE; CELL STIMULATION; CHIMERA; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; EPISOME; FOLLOW UP; GENE DOSAGE; GENE EXPRESSION; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HUMAN; HUMAN CHROMOSOME; HUMAN CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 6 INTEGRATED IN HOST CHROMOSOME; IN VIVO STUDY; LETTER; LEUKOPENIA; LIVER GRAFT; LIVER TRANSPLANTATION; MYELODYSPLASTIC SYNDROME; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; VIRUS GENE; VIRUS INFECTION; VIRUS LOAD; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS VIRULENCE;

CHROMOSOMES; FEMALE; GRAFT REJECTION; HERPESVIRUS 6, HUMAN; HUMANS; LIVER TRANSPLANTATION; MALE; OPPORTUNISTIC INFECTIONS; ROSEOLOVIRUS INFECTIONS; TRANSPLANTATION;

EID: 80054966641     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182339d1a     Document Type: Letter

References (7)

1. Lee SO, Brown RA, Razonable RR. Clinical significance of pretransplant chromosomally integrated human herpesvirus-6 in liver transplant recipients. Transplantation 2011; 92: 224.
2. Humar A, Kumar D, Caliendo AM, et al. Clinical impact ofhumanherpesvirus 6 infection after liver transplantation. Transplantation 2002; 73: 599.
3. Arbuckle JH, Medveczky MM, Luka J, et al. The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro. Proc Natl Acad Sci USA 2010; 107: 5563.
4. Potenza, L, Barozzi P, Masetti M, et al. Prevalence of human herpesvirus-6 chromosomal integration (CIHHV-6) in Italian solid organ and allogeneic stem cell transplant patients.AmJ Transplant 2009; 9: 1690.
5. Hubacek P, Hyncicova K, Muzikova K, et al. Disappearance of pre-existing high HHV-6 DNA load in blood after allogeneic SCT. Bone Marrow Transplant 2007; 40: 805.
6. Söderberg-Nauclér C, Fish KN, Nelson JA. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 1997; 91: 119.
7. Clark DA, Griffiths PD.Humanherpesvirus-6: Relevance of infection in the immunocompromised host. Br J Haematol 2003; 120: 384.